Aging CellPhysiologyPeer-reviewed journal article
Chronic activation of a key exercise signal transducer, CaMKII, drives skeletal muscle aging and sarcopenia
Michael R. BeneiD, Tae ChungiD, Elizabeth D. LuczakiD, Gabriel A. Lopez-CecetaiteiD, William A. FountainiD, Giovanni Rosales‐SotoiD, Erick O. Hernández‐OchoaiD, Corina M. AntonescuiD, Liliana FloreaiD, Seeun J. JeongiD, Emily ElassaliD, Anne LeiD, Qian-Li XueiD, Ahmet HökeiD, Peter M. AbadiriD, Qinchuan WangiD
Abstract
Sarcopenia, the age-related loss of muscle strength and mass, contributes to adverse health outcomes in older adults. While exercise mitigates sarcopenia by transiently activating calcium (Ca2+)- and reactive oxygen species (ROS)-dependent signaling pathways that enhance muscle performance and adaptation, these same signals become chronically elevated in aged skeletal muscle and promote functional decline. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a key transducer of both Ca2+ and ROS signals during exercise. Here we show that CaMKII is chronically activated in aged muscles, promoting muscle dysfunction. Muscle-specific expression of a constitutively active CaMKII construct in young mice recapitulates features of aging muscles, including impaired contractility, progressive atrophy, mitochondrial disorganization, formation of tubular aggregates, and an older transcriptional profile characterized by the activation of inflammatory and stress response pathways. Mediation analysis identified altered heme metabolism as a potential mechanism of CaMKII-induced weakness, independent of muscle atrophy. Conversely, partial inhibition of CaMKII in aged muscle improved contractile function and shifted the transcriptome toward a more youthful state without inducing hypertrophy. These findings identify chronic CaMKII activation as a driver of functional and molecular muscle aging and support the concept that CaMKII exemplifies antagonistic pleiotropy, whereby its beneficial roles in promoting muscle performance and adaptation during youth may incur deleterious consequences in aging. We propose that persistent CaMKII activation in aged skeletal muscle reflects unresolved cellular stress and promotes maladaptive remodeling. Enhancing physiological reserve capacity through exercise, in combination with temporally targeted CaMKII inhibition, may help restore adaptive CaMKII signaling dynamics and preserve muscle function in aging.
- organism: mouse
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: metabolism & bioenergetics
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 46%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased mitochondrial Ca2+ contributes to health decline with age and Duchene muscular dystrophy in C. elegans.
A. Higashitani, M. Teranishi, … T. Kobayashi·bioRxiv·Jul 8, 2022
- Unveiling Ageing-Associated and Caloric Restriction-Associated Changes in miRNA Expression in Rat Skeletal Muscle and the Mechanisms Mediating their Effects on Muscle Cell Function
Gulum Altab, Brian J. Merry, … João Pedro de Magalhães·bioRxiv·Apr 7, 2024
- Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle
D. J. Ham, A. Boersch, … M. A. Ruegg·bioRxiv·May 28, 2021
- PGC-1α regulates mitochondrial calcium homeostasis, SR stress and cell death to mitigate skeletal muscle aging
J. F. Gill, J. Delezie, … C. Handschin·bioRxiv·Oct 23, 2018
- Calcium and strontium contractile activation properties of single skinned skeletal muscle fibres from elderly women 66-90 years of age
S. M. Ronaldson, G. D. Stephenson, S. I. Head·bioRxiv·Nov 8, 2021
- The impact of physical activity on physical performance, mitochondrial bioenergetics, ROS production and calcium handling across the human adult lifespan
Marina Cefis, Vincent Marcangeli, … Gilles Gouspillou·Cell Reports MedicinePeer-reviewed·Feb 1, 2025